Seroprevalence of Antibodies against Chikungunya, Dengue, and Rift Valley Fever Viruses after Febrile Illness Outbreak, Madagascar
Norbert G. Schwarz
1
, Mirko Girmann
1, Njary Randriamampionona, Alexandra Bialonski, Deborah Maus, Anne Caroline Krefis, Christine Njarasoa, Jeanne Fleury Rajanalison, Herly Daniel Ramandrisoa, Maurice Lucien Randriarison, Jürgen May, Jonas Schmidt-Chanasit, and Raphael Rakotozandrindrainy
Author affiliations: Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany (N.G. Schwarz, M. Girmann, A.C. Krefis, J. May); World Health Organization Collaborating Centre for Arbovirus and Haemorrhagic Fever Reference and Research, Hamburg (A. Bialonski, D. Maus, J. Schmidt-Chanasit); Université d’Antananarivo, Antananarivo, Madagascar (N. Randriamampionona, R. Rakotozandrindrainy); Hôpital d’Ambositra, Ambositra, Madagascar (C. Jnarasoa); Medecin Inspecteur de Tsiroanomandidy, Tsiroanomandidy, Madagascar (J.F. Rajanalison); Medecin Inspecteur de Moramanga, Moramanga, Madagascar (H.D. Ramandrisoa); and Centre de Santé de Base Urban de Mananjary,Mananjary, Madagascar (M.L. Randriarison)
Main Article
Table 2
Signs and symptoms of pregnant women with IgG against CHIKV from Mananjary and Manakara, Madagascar, May–July 2010*
Symptom/sign |
No. (%) women with
|
IgG against CHIKV, n = 144 |
IgG against DENV, n = 61 |
Fever |
107 (74) |
21 (34) |
Joint pain and stiffness |
113 (78) |
22 (36) |
Skin symptoms or rashes |
87 (60) |
19 (31) |
Hip vibrations and pain |
84 (58) |
20 (33) |
Stooped posture† |
77 (53) |
18 (30) |
Conjunctivitis |
27 (18) |
9 (15) |
Asymptomatic |
30 (21) |
39 (64) |
Main Article
Page created: October 15, 2012
Page updated: October 15, 2012
Page reviewed: October 15, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.